ArticleRisk management and healthcare policy2024

A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis.

Shuo Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.